Professor Hrdy moderated a panel on trademark law at Penn Law on Friday. The panel, entitled, “How Far Should Trademark Protection Extend?” was hosted by the Penn Intellectual Property Group (PIPG) for their Annual Symposium, which took place on Friday, March 21, 2025, at University of Pennsylvania Carey Law School. The Panelists, pictured above, were: … Continue reading Professor Hrdy Moderates Trademark Law Panel at Penn Law, Asking “Should Strong Marks Get Greater Protection”?…
Category: News
Professor Hrdy Discusses New Generative AI Trade Secrets Case in Bloomberg Law
Prof. Camilla Hrdy was quoted in Bloomberg Law about a new trade secrets case, OpenEvidence v. Pathway, in which a generative AI company accused a competitor of stealing trade secrets. Hrdy blogs on the new trade secret case here. The Bloomberg Law article states, in relevant part: “This is exactly the kind of case I … Continue reading Professor Hrdy Discusses New Generative AI Trade Secrets Case in Bloomberg Law…
Prof. Hrdy Presents at Temple Law IP Colloquium
Professor Camilla Hrdy presented her new article on trade secrets and generative AI at the Temple University Beasley School of Law IP Colloquium on February 18, 2025. Prof. Hrdy joined Temple Law professors, Guy Rub, Paul Gugliuzza, and Salil Mehra, for a fascinating discussion with students about whether generative AI products like ChatGPT are protected … Continue reading Prof. Hrdy Presents at Temple Law IP Colloquium…
Prof. Goodman gives keynote at Silicon Flatirons Flagship conference.
Professor Ellen P. Goodman gave a keynote address at Silicon Flatirons Flagship conference: Examining the New Federalism in Technology Policy. She spoke about state AI governance efforts.
Prof. Carrier co-authors “PBMs and Product Hopping” article
Professor Michael Carrier published PBMs and Product Hopping (with Victoria Field) in CPI Antitrust Chronicle. The article explores two reasons for higher drug prices that have previously been examined separately–pharmacy benefit managers (PBMs) and “product hopping” from one drug to another–but have not yet been considered in combination.